Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms HELP
Based on 31,636 articles published since 2008
|||| 49 

These are the 31636 published articles about Pancreatic Neoplasms that originated from Worldwide during 2008-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
476 Editorial The new concept of therapeutic strategy for neuroendocrine tumors: important information from a case report of gastrinoma. 2010

Igarashi, Hisato / Ito, Tetsuhide / Takayanagi, Ryoichi. · ·Intern Med · Pubmed #20823641.

ABSTRACT: -- No abstract --

477 Editorial Refinement of adjuvant therapy for pancreatic cancer. 2010

O'Reilly, Eileen M. · ·JAMA · Pubmed #20823441.

ABSTRACT: -- No abstract --

478 Editorial Small tumors, intermediate models, big hopes. 2010

Siu, Lillian L. · ·J Clin Oncol · Pubmed #20823413.

ABSTRACT: -- No abstract --

479 Editorial Mass spectrometry based proteomic profiling for pancreatic cancer. 2010

Pawa, Nikhil / Wright, James M / Arulampalam, Tan H A. · ·JOP · Pubmed #20818108.

ABSTRACT: -- No abstract --

480 Editorial Distal pancreatectomy: another indication for prophylactic pancreatic stenting? 2010

Dumonceau, Jean-Marc. · ·Gastrointest Endosc · Pubmed #20801287.

ABSTRACT: -- No abstract --

481 Editorial Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy. 2010

Evans, Douglas B / Erickson, Beth A / Ritch, Paul. · ·Ann Surg Oncol · Pubmed #20737218.

ABSTRACT: -- No abstract --

482 Editorial Radiofrequency ablation of locally advanced pancreatic adenocarcinoma: an overview. 2010

D'Onofrio, Mirko / Barbi, Emilio / Girelli, Roberto / Martone, Enrico / Gallotti, Anna / Salvia, Roberto / Martini, Paolo-Tinazzi / Bassi, Claudio / Pederzoli, Paolo / Pozzi Mucelli, Roberto. ·Department of Radiology, University Hospital G.B. Rossi, University of Verona, Piazzale L.A. Scuro 10, Verona 37134, Italy. mirko.donofrio@univr.it ·World J Gastroenterol · Pubmed #20653055.

ABSTRACT: Radiofrequency ablation (RFA) of pancreatic neoplasms is restricted to locally advanced, non-resectable but non-metastatic tumors. RFA of pancreatic tumors is nowadays an ultrasound-guided procedure performed during laparotomy in open surgery. Intraoperative ultrasound covers the mandatory role of staging, evaluation of feasibility, guidance and monitoring of the procedure. Different types of needle can be used. The first aim in the evaluation of RFA as a treatment for locally advanced pancreatic ductal adenocarcinoma, in order of evaluation but not of importance, is to determine the feasibility of the procedure. The second aim is to establish the effect of RFA on tumoral mass in terms of necrosis and cytoreduction. The most important aim, third in order of evaluation, is the potential improvement of quality of life and survival rate. Nowadays, only a few studies assess the feasibility of the procedure. The present paper is an overview of RFA for pancreatic adenocarcinoma.

483 Editorial [The present status, difficulty and strategy of pancreatic cancer therapy]. 2010

Guo, Xiao-zhong. · ·Zhonghua Nei Ke Za Zhi · Pubmed #20627028.

ABSTRACT: -- No abstract --

484 Editorial Novel therapies for pancreatic cancer: setbacks and progress. 2010

Wong, Han Hsi / Lemoine, Nicholas R. · ·Future Oncol · Pubmed #20624116.

ABSTRACT: -- No abstract --

485 Editorial Pancreatic surgery 101: drain, no drain, early drain removal, or late drain removal. What are the data? Where do we go from here? 2010

Yeo, Charles J. · ·Ann Surg · Pubmed #20622651.

ABSTRACT: -- No abstract --

486 Editorial Survival in pancreatic cancer: the best is yet to come. 2010

Sauer, Bryan G / Shami, Vanessa M. · ·Gastrointest Endosc · Pubmed #20620275.

ABSTRACT: -- No abstract --

487 Editorial Cachexia in pancreatic cancer: new treatment options and measures of success. 2010

Fearon, Kenneth C H / Baracos, Vickie E. · ·HPB (Oxford) · Pubmed #20590907.

ABSTRACT: -- No abstract --

488 Editorial Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors. 2010

Strosberg, Jonathan / Kvols, Larry. · ·World J Gastroenterol · Pubmed #20572298.

ABSTRACT: Somatostatin analogs were initially developed for the control of hormonal syndromes associated with neuroendocrine tumors (NETs). In recent years, accumulating data has supported their role as antiproliferative agents, capable of stabilizing tumor growth in patients with metastatic neuroendocrine malignancies, including carcinoid and pancreatic endocrine tumors. A phase III, randomized, placebo-controlled trial has now demonstrated that octreotide long-acting repeatable (LAR) 30 mg can significantly prolong time to tumor progression among patients with metastatic midgut NETs regardless of functional status, chromogranin A level or age. In addition to significantly lengthening time to tumor progression in the overall study population, subset analysis suggests that patients with low tumor burden are most likely to experience disease stabilization with octreotide LAR 30 mg, supporting the early use of octreotide LAR in patients with metastatic disease. Further research efforts are underway to evaluate the use of somatostatin analogs as antiproliferative agents in other types of gastroenteropancreatic-NETs. Ongoing studies are also evaluating novel somatostatin analogs and somatostatin analogs in combination with other anti-tumor therapies.

489 Editorial Intraductal papillary mucinous neoplasm of the pancreas: an emerging indication for surgical therapy. 2010

Carballo-Alvarez, F. · ·Rev Esp Enferm Dig · Pubmed #20524755.

ABSTRACT: -- No abstract --

490 Editorial Adjuvant pancreatic cancer therapy: no one should go it alone or be left behind. 2010

Herman, Joseph M / Regine, William F. · ·Int J Radiat Oncol Biol Phys · Pubmed #20510192.

ABSTRACT: -- No abstract --

491 Editorial A tale of two provinces: regionalization of pancreatic surgery in Ontario and Quebec. 2010

Sonnenday, Christopher J / Birkmeyer, John D. · ·Ann Surg Oncol · Pubmed #20499281.

ABSTRACT: -- No abstract --

492 Editorial R0 in pancreatic cancer surgery: surgery, pathology, biology, or definition matters? 2010

Büchler, Markus W / Werner, Jens / Weitz, Jürgen. · ·Ann Surg · Pubmed #20485128.

ABSTRACT: -- No abstract --

493 Editorial Management of pancreatic cystic neoplasms: decision-making with limited information. 2010

Park, Walter G / Chari, Suresh T. · ·Pancreatology · Pubmed #20460945.

ABSTRACT: -- No abstract --

494 Editorial Pancreatic cancer in chronic hepatitis B. 2010

Sherman, Morris. · ·Liver Int · Pubmed #20456036.

ABSTRACT: -- No abstract --

495 Editorial [Pancreatic cancer 2010]. 2010

Burcharth, Flemming. · ·Ugeskr Laeger · Pubmed #20444402.

ABSTRACT: -- No abstract --

496 Editorial Inflammation and pancreatic ductal adenocarcinoma: a potential scenario for novel drug targets. 2010

Uomo, Ilaria / Miraglia, Simona / Pastorello, Maurizio. · ·JOP · Pubmed #20442512.

ABSTRACT: -- No abstract --

497 Editorial The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. 2010

Klöppel, Günter / Rindi, Guido / Perren, Aurel / Komminoth, Paul / Klimstra, David S. · ·Virchows Arch · Pubmed #20422210.

ABSTRACT: -- No abstract --

498 Editorial The plastic biliary stent: an obsolete device for managing pancreatic cancer? 2010

Rogart, Jason N. · ·J Clin Gastroenterol · Pubmed #20421801.

ABSTRACT: -- No abstract --

499 Editorial Any progress in pancreatic cancer? Well, but progress for Acta Oncologica. 2010

Glimelius, Bengt. · ·Acta Oncol · Pubmed #20397771.

ABSTRACT: -- No abstract --

500 Editorial Pylorus preserving pancreaticoduodenectomy. 2010

Nikfarjam, Mehrdad. · ·Saudi J Gastroenterol · Pubmed #20339172.

ABSTRACT: -- No abstract --

Back